Back

Comparative characteristics of patients with and without transthyretin amyloid cardiomyopathy in the TTRACK study population

17 May 2025 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Pathophysioloy and prognosis on heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Francesco Cappelli

Careggi University Hospital (AOUC), Florence (Italy)

3 More presentations in this session

Presentation thumbnail
Machine learning-based phenogrouping for clinical outcomes and treatment response in patients with chronic heart failure
Doctor M. Nakao (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Effect of paracetamol on cardiovascular outcomes in patients with heart failure: a multi-center cohort study
Doctor Q. Ren (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
The neutrophil to lymphocyte ratio (NRL) as a predictor of nutritional status in patients with heart failure with reduced ejection fraction
Miss M. Cierzniak (Poznan, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysioloy and prognosis on heart failure

The Event

Event poster

Heart Failure 2025

17 May 2025 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Age- and sex-related trends in transthyretin amyloid cardiomyopathy prevalence in older patients with unexplained hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: clinical, cardiac imaging, and electrocardiographic findings from the TTRACK study
thumbnail
Congress Presentation
Prevalence and characteristics of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: final analysis of the TTRACK study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources